Back to Agenda
Panel Discussion: How innovative advances are reshaping regulatory process
Session Chair(s)
Shun Jin, MBA
Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
How innovative advances are reshaping regulatory processes
Speaker(s)
Contributing Panelist
Yuta Maeda
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Coordinator, Division of Asia II, Office of International Programs
Contributing Panelist
Mei-Chen Huang
TFDA, Taiwan
Section Chief, Division of Medicinal Products
Contributing Panelist
Nina S. Cauchon, PhD
Amgen, United States
Director Regulatory Affairs CMC
Contributing Panelist
Dominique Lagrave, PharmD
Accumulus Synergy, United States
Senior Vice President of Regulatory Innovation
Have an account?